Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy
Start Date
9/30/2025
Completion Date
12/31/2026
Summary
The goal of this study is to develop an educational aid about hormone replacement therapy that physicians can share with patients as part of their pre-surgical counseling for a risk-reducing salpingo-oophorectomy (RRSO).
Detailed Description
The proposed randomized study seeks to enroll 50 individuals from gynecologic oncology and high-risk breast clinics who are actively planning RRSO. Participants will be randomized to usual provider education versus usual education plus video education. The researchers will assess participants' level of conflict around the decision to use HRT, their satisfaction with their decision, their satisfaction with their counseling, and their postoperative decision regarding HRT. This project will provide pilot data for a larger randomized trial. Ultimately, the investigators seek to create a comprehensive aid for education and values clarification, with the aim of improving informed decision making for individuals with BRCA1-2 mutations.
Eligibility Criteria
Age Range: 19 years to 50 years
Interventions
Experimental Arm
SOC Arm
Conditions
Locations
UNC Chapel Hill Health System
Chapel Hill, North Carolina 27514
United States
Duke University Health System
Durham, North Carolina 27710
United States